韓國Bioneer  www.bioneer.com
BIONEER公司是韓國KOSDAQ上市的著名生物科技企業(yè)(Kosdaq:064550)，于1992年由樸翰浯(Han-Oh Park, Ph.D.)博士創(chuàng)建，總部設(shè)在韓國大田，擁有雄厚的科研實(shí)力，并承擔(dān)有韓國科技部大量研究項(xiàng)目。憑借優(yōu)異的產(chǎn)品質(zhì)量、先進(jìn)的生產(chǎn)管理經(jīng)驗(yàn)，Bioneer通過了ISO9001和ISO13485產(chǎn)品質(zhì)量體系認(rèn)證。2005年在美國成立了全資子公司，并建有22,000平米的寡核苷酸合成基地。目前Bioneer在全球四十多個國家擁有銷售網(wǎng)絡(luò)，擁有全球最大的寡核苷酸合成規(guī)模，韓國國內(nèi)外專利170多項(xiàng)，產(chǎn)品覆蓋生命科學(xué)、基因組學(xué)、基因診斷和基因治療等領(lǐng)域.
秉承“科技造福人類”的創(chuàng)業(yè)理念，Bioneer公司于2008年8月在中國成立了全資子公司——柏業(yè)貿(mào)易（上海）有限公司。我們將會以極具競爭力的價格提供一流的產(chǎn)品和專業(yè)的服務(wù)，期望能為中國廣大科研工作者提供幫助。請相信：在您成功走向科研殿堂的路上，Bioneer會忠誠地伴隨在您左右。
BIONEER公司主要產(chǎn)品：
儀器——全自動核酸提取儀、實(shí)時定量、梯度、常規(guī)PCR儀、混勻離心雙功能機(jī)、電泳系統(tǒng)等
試劑——DNA/RNA提取純化、獨(dú)特PCR Premix、酶及DNA標(biāo)準(zhǔn)物
合成服務(wù)——引物、探針、siRNA等合成及修飾服務(wù)
藥物開發(fā)——S.pombe藥物篩選系統(tǒng)
分子診斷試劑

柏業(yè)貿(mào)易(上海)有限公司
電話：021-5080-0969/1191
傳真：021-5080-1620
地址：上海浦東張江高科技園區(qū)祖沖之路887弄88號樓4F北區(qū)，201203
網(wǎng)址：http://www.bioneercn.com
技術(shù)支持
電話：總機(jī)轉(zhuǎn)802
Email：ascn@bioneer.com
試劑、儀器、合成訂貨
電話：總機(jī)轉(zhuǎn)805
Email：salescn@bioneer.com

公司財務(wù)信息
開戶行：中國建設(shè)銀行張江支行
戶名：柏業(yè)貿(mào)易（上海）有限公司
賬號：31001523211050013456
稅務(wù)登記號：滬字310112679362613
Bioneer Corporation is the first Korean biotechnology company established in 1992. The company has developed state of art molecular biology products and technologies including oligonucleotides, thermostable polymerases, and instruments of gene manipulation (automatic nucleic acid extractor, thermal cycler, real-time QPCR instruments and DNA sequencer). From its inception, Bioneer has invested in the integration of recombinant DNA technology, fermentation, biochemistry and nucleic acid chemistry in addition to mechanics, photonics and electronics. The company is positioned to fully-integrate its capability to develop next generation technologies in the post-genome era through the invention of new biochemistry and instruments. Bioneer now runs two production and research facilities in Korea which are a total of 226,000 square feet. Equipped with proprietary 384 synthesizers, these facilities contain a full production line for oligonucleotide and siRNA synthesis. In addition to DNA manufacturing, Bioneer processes recombinant proteins which are fermented and purified on proprietary purification systems.
After a successful Initial Public Offering in December 2005, Bioneer Corp. launched Bioneer Inc., the wholly owned subsidiary. The American subsidiary is located in a 22,000 square foot production and distribution facility in Alameda, CA, the heart of the San Francisco Bay Area. The company is dedicated to providing state of art solutions to the global community of life science researchers in academia, biotech and pharmaceutical companies.